Patient NAME : Mr A RAGHAVENDRA CHARYULU

DOB/Age/Gender : 40 Y 9 M 13 D/Male Report STATUS : Final Report

Patient ID / UHID : 11842044/RCL11097838 Barcode NO : 989454545444
Referred BY : Self Sample Type : Whole blood EDTA
....

Sample Collected : Mar 25, 2025, 07:49 AM Report Date : Mar 25, 2025, 10:44 AM.
Test Description Value(s) Unit(s) Reference Range

Master Pro Full Body Checkup - Male

Complete Blood Count (CBC)

RBC Parameters
Hemoglobin 15.8 g/dL 13.0 - 17.0
Cyanide free spectrophotometry.
RBC Count 4.6 10^6/µl 4.5 - 5.5
Electrical impedance
PCV 45.9 % 40 - 50
Calculated
MCV 99 fl 83 - 101
Calculated
MCH 34.1 pg 27 - 32
Calculated
MCHC 34.4 g/dL 31.5 - 34.5
Calculated
RDW (CV) 18 % 11.6 - 14.0
Calculated
RDW-SD 58.8 fl 35.1 - 43.9
Calculated
WBC Parameters
TLC 7.3 10^3/µl 4 - 10
Electrical Impedence(Leishman stain)
Differential Leucocyte Count
Neutrophils 64.8 % 40-80
Double hydrodynamic sequential system
Lymphocytes 26.9 % 20-40
Double hydrodynamic sequential system
Monocytes 5.7 % 2-10
Double hydrodynamic sequential system
Eosinophils 1.7 % 1-6
Double hydrodynamic sequential system
Basophils 0.9 % <2
Double hydrodynamic sequential system
Absolute Leukocyte Counts
Calculated
Neutrophils. 4.73 10^3/µl 2-7
Lymphocytes. 1.96 10^3/µl 1-3
Calculated
Monocytes. 0.42 10^3/µl 0.2 - 1.0
Calculated
Eosinophils. 0.12 10^3/µl 0.02 - 0.5
Basophils. 0.07 10^3/µl 0.02 - 0.5
Platelet Parameters

Booking Centre :- Home Collection

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., Building No.168,First Floor Sarathy,9 Main Sector 6 HRS Layout,
Bangalore 560102

Page 1 of 26
Patient NAME : Mr A RAGHAVENDRA CHARYULU
DOB/Age/Gender : 40 Y 9 M 13 D/Male Report STATUS : Final Report
Patient ID / UHID : 11842044/RCL11097838 Barcode NO : 989454545444
Referred BY : Self Sample Type : Whole blood EDTA
Sample Collected : Mar 25, 2025, 07:49 AM Report Date : Mar 25, 2025, 10:44 AM.
Test Description Value(s) Unit(s) Reference Range
Platelet Count 216 10^3/µl 150 - 410
Electrical impedance(Leishman stain)
Mean Platelet Volume (MPV) 7.1 fL 9.3 - 12.1
Calculated
PCT 0.2 % 0.17 - 0.32
Calculated
PDW 10.1 fL 8.3 - 25.0
Calculated
P-LCR 13.5 % 18 - 50
Calculated
P-LCC 29 10^9/L 44 - 140
Calculated
Mentzer Index 21.52 % -
Calculated

Interpretation:
CBC provides information about red cells, white cells and platelets. Results are useful in the diagnosis of anemia, infections, leukemias, clotting
disorders and many other medical conditions.

Booking Centre :- Home Collection

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., Building No.168,First Floor Sarathy,9 Main Sector 6 HRS Layout,
Bangalore 560102

Page 2 of 26
 Patient NAME : Mr A RAGHAVENDRA CHARYULU
DOB/Age/Gender : 40 Y 9 M 13 D/Male Report STATUS : Final Report
Patient ID / UHID : 11842044/RCL11097838 Barcode NO : 989454545444
Referred BY : Self Sample Type : Whole blood EDTA
....

Sample Collected : Mar 25, 2025, 07:49 AM Report Date : Mar 25, 2025, 10:44 AM.
Test Description Value(s) Unit(s) Reference Range

Erythrocyte Sedimentation Rate (ESR)

ESR - Erythrocyte Sedimentation Rate 17 mm/hr 0 - 10

MODIFIED WESTERGREN

Interpretation:
ESR is also known as Erythrocyte Sedimentation Rate. An ESR test is used to assess inflammation in the body. Many conditions can cause an
abnormal ESR, so an ESR test is typically used with other tests to diagnose and monitor different diseases. An elevated ESR may occur in
inflammatory conditions including infection, rheumatoid arthritis ,systemic vasculitis, anemia, multiple myeloma , etc. Low levels are typically
seen in congestive heart failure, polycythemia ,sickle cell anemia, hypo fibrinogenemia , etc.

Reference- Dacie and lewis practical hematology

Booking Centre :- Home Collection

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., Building No.168,First Floor Sarathy,9 Main Sector 6 HRS Layout,
Bangalore 560102

Page 3 of 26
 Patient NAME : Mr A RAGHAVENDRA CHARYULU
DOB/Age/Gender : 40 Y 9 M 13 D/Male Report STATUS : Final Report
Patient ID / UHID : 11842044/RCL11097838 Barcode NO : 989454545444
Referred BY : Self Sample Type : Whole blood EDTA
....

Sample Collected : Mar 25, 2025, 07:49 AM Report Date : Mar 25, 2025, 01:47 PM.
Test Description Value(s) Unit(s) Reference Range

HbA1C (Glycosylated Haemoglobin)

Glycosylated Hemoglobin (HbA1c) 6.1 % <5.7

HPLC
Estimated Average Glucose 128.37
calculated.

Interpretation:
Interpretation For HbA1c% As per American Diabetes Association (ADA)
Reference Group HbA1c in %
Non diabetic adults >=18 years <5.7
At risk (Prediabetes) 5.7 - 6.4
Diagnosing Diabetes >= 6.5
Age > 19 years
Goal of therapy: < 7.0
Therapeutic goals for glycemic control
Age < 19 years
Goal of therapy: <7.5

Note:
1. Since HbA1c reflects long term fluctuations in the blood glucose concentration, a diabetic patient who is recently under good control may still
have a high concentration of HbA1c. Converse is true for a diabetic previously under good control but now poorly controlled.
2. Target goals of < 7.0 % may be beneficial in patients with short duration of diabetes, long life expectancy and no significant cardiovascular
disease. In patients with significant complications of diabetes, limited life expectancy or extensive co-morbid conditions, targeting a goal of < 7.0 %
may not be appropriate.

Comments :
HbA1c provides an index of average blood glucose levels over the past 8 - 12 weeks and is a much better indicator of long term glycemic control as
compared to blood and urinary glucose determinations ADA criteria for correlation between HbA1c & Mean plasma glucose levels.
HbA1c(%) Mean Plasma Glucose (mg/dL) HbA1c(%) Mean Plasma Glucose (mg/dL)
6 126 12 298
8 183 14 355
10 240 16 413

Booking Centre :- Home Collection

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., Building No.168,First Floor Sarathy,9 Main Sector 6 HRS Layout,
Bangalore 560102

Page 4 of 26
 Patient NAME : Mr A RAGHAVENDRA CHARYULU
DOB/Age/Gender : 40 Y 9 M 13 D/Male Report STATUS : Final Report
Patient ID / UHID : 11842044/RCL11097838 Barcode NO : 12232356644
Referred BY : Self Sample Type : FLUORIDE F
....

Sample Collected : Mar 25, 2025, 07:49 AM Report Date : Mar 25, 2025, 10:43 AM.
Test Description Value(s) Unit(s) Reference Range

Glucose Fasting

Glucose Fasting 131 mg/dL 70 - 100

Hexokinase

Interpretation:
Status Fasting plasma glucose in mg/dL
Normal <100
Impaired fasting glucose 100 - 125
Diabetes =>126

Reference : American Diabetes Association

Comment :
Blood glucose determinations in commonly used as an aid in the diagnosis and treatment of diabetes. Elevated glucose levels (hyperglycemia)
may also occur with pancreatic neoplasm, hyperthyroidism, and adrenal cortical hyper function as well as other disorders. Decreased glucose
levels (hypoglycemia) may result from excessive insulin therapy insulinoma, or various liver diseases.

Note
1.The diagnosis of Diabetes requires a fasting plasma glucose of > or = 126 mg/dL or a random / 2 hour plasma glucose value of > or = 200
mg/dL with symptoms of diabetes mellitus.
2.Very high glucose levels (>450 mg/dL in adults) may result in Diabetic Ketoacidosis.

Booking Centre :- Home Collection

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., Building No.168,First Floor Sarathy,9 Main Sector 6 HRS Layout,
Bangalore 560102

Page 5 of 26
 Patient NAME : Mr A RAGHAVENDRA CHARYULU
DOB/Age/Gender : 40 Y 9 M 13 D/Male Report STATUS : Final Report
Patient ID / UHID : 11842044/RCL11097838 Barcode NO : BI9656565111
Referred BY : Self Sample Type : Serum
....

Sample Collected : Mar 25, 2025, 07:49 AM Report Date : Mar 25, 2025, 12:33 PM.
Test Description Value(s) Unit(s) Reference Range

Liver Function Test (LFT)

Bilirubin Total 2.04 mg/dL 0.2 - 1.2

diazonium salt
Bilirubin Direct 0.52 mg/dL 0.0 - 0.5
Diazo Reaction
Bilirubin Indirect 1.52 mg/dL 0.1 - 1.0
Calculation (T Bil - D Bil)
SGOT/AST 18 U/L 5 - 34
Enzymatic {NADH (without P5P)}
SGPT/ALT 26 U/L 0 to 55
Enzymatic {NADH (without P5P)}
SGOT/SGPT Ratio 0.69 - -
calculated
Alkaline Phosphatase 126 U/L 40 - 150
paranitrophenyl phosphate
Total Protein 7.9 g/dL 6.4 - 8.3
Biuret
Albumin 4.99 gm/dL 3.8 - 5.0
BCG
Globulin 2.91 g/dL 2.3 - 3.5
Calculation (T.P - Albumin)
Albumin :Globulin Ratio 1.71 - 1.0 - 2.1
Calculation (Albumin/Globulin)
Gamma Glutamyl Transferase (GGT) 40 U/L 12 - 64
Photometric

Interpretation:
The liver filters blood, metabolizes nutrients, detoxifies harmful substances, and produces blood clotting proteins. Liver cells contain
enzymes that facilitate these functions. When cells are damaged, enzymes leak into the blood, detectable through blood tests.

Key enzymes tested:

1. AST (SGOT): may indicate tissue injury / damage in muscles or liver.

2. ALT (SGPT): Primarily in the liver. Elevated ALT and AST suggest liver damage.
3. Alkaline Phosphatase & GGT: Linked to bile production and flow. Elevated levels may indicate bile flow issues related to the liver,
gallbladder, or bile ducts.

Blood proteins, albumin and globulin, are essential for growth, development, and health.

1. Low protein: May indicate bleeding, liver disorders, malnutrition, or agammaglobulinemia.

2. High protein (Hyperproteinemia): Often due to dehydration or increased protein production.
3. Low albumin: Caused by poor diet, kidney, or liver disease.
4. High albumin: Usually due to severe dehydration.

Booking Centre :- Home Collection

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., Building No.168,First Floor Sarathy,9 Main Sector 6 HRS Layout,
Bangalore 560102

Page 6 of 26
 Patient NAME : Mr A RAGHAVENDRA CHARYULU
DOB/Age/Gender : 40 Y 9 M 13 D/Male Report STATUS : Final Report
Patient ID / UHID : 11842044/RCL11097838 Barcode NO : BI9656565111
Referred BY : Self Sample Type : Serum
....

Sample Collected : Mar 25, 2025, 07:49 AM Report Date : Mar 25, 2025, 12:33 PM.
Test Description Value(s) Unit(s) Reference Range

Kidney Function Test (KFT)

Blood Urea 15.194 mg/dL 19 - 44.1

Calculated
Bun 7.1 mg/dL 8.9 - 20.6
Urease
Creatinine 0.69 mg/dL 0.72 - 1.25
kinetic alkaline picrate
eGFR (CKD-EPI) 119.37 ml/min/1.73 sq m Normal Or High: >= 90

Mild Or Decrease: 60-89

Mild To Moderate Decrease:

45-59

Mild To Severe Decrease:

30-44

Severe Decrease: 15-29

Kidney Failure: < 15

Bun/Creatinine Ratio 10.29 12 - 20
calculated
Urea / Creatinine Ratio 22.02 25.68- 42.8
Calculated
Uric Acid 4.1 mg/dL 3.5 - 7.2
Uricase
Calcium Serum 9.5 mg/dL 8.4 - 10.2
Arsenazo III
Phosphorus 3.1 mg/dL 2.3 - 4.7
phosphomolybdate.
Sodium 139 mmol/L 136 - 145
Ion selective Electrode-Indirect.
Potassium 4.8 mmol/L 3.5 - 5.1
Ion selective Electrode-Indirect.
Chloride 100 mmol/L 98 - 107
Ion selective Electrode-Indirect.

Interpretation:
Kidney function tests is a collective term for a variety of individual tests and proceduresthat can be done toevaluate how well the kidneys are functioning. Many
conditions can affect the ability of the kidneys to carryout their vital functions. Somelead to a rapid (acute) decline in kidney functionothers lead to a gradual (chronic)
declineinfunction. Both result in a buildup of toxic waste subst done on urine samples, as well as on blood samples. A number of symptoms may indicate a problem with
your kidneys. These include : high blood pressure,blood in urine frequent urges to urinate,difficulty beginning urination,painful urination,swelling in the hands and feet due
to a buildup of fluids in the body. A single symptom may not mean something serious. However, when occurring simultaneously, these symptoms suggest that your
kidneys are not working properly. Kidney function tests can help determine the reason. Electrolytes are present in the human body and the balancing act of the
electrolytes in our bodies is essential for normal function of our cells and organs. There has to be a balance.Ionized calcium this test if you have signs of kidney or
parathyroid disease. The test may also be done to monitor progress and treatment of these diseases.
"eGFR test is applicable for patients aged 18 years or more."

Booking Centre :- Home Collection

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., Building No.168,First Floor Sarathy,9 Main Sector 6 HRS Layout,
Bangalore 560102

Page 7 of 26
Patient NAME : Mr A RAGHAVENDRA CHARYULU
DOB/Age/Gender : 40 Y 9 M 13 D/Male Report STATUS : Final Report
Patient ID / UHID : 11842044/RCL11097838 Barcode NO : BI9656565111
Referred BY : Self Sample Type : Serum
Sample Collected : Mar 25, 2025, 07:49 AM Report Date : Mar 25, 2025, 12:33 PM.
Test Description Value(s) Unit(s) Reference Range

Booking Centre :- Home Collection

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., Building No.168,First Floor Sarathy,9 Main Sector 6 HRS Layout,
Bangalore 560102

Page 8 of 26
 Patient NAME : Mr A RAGHAVENDRA CHARYULU
DOB/Age/Gender : 40 Y 9 M 13 D/Male Report STATUS : Final Report
Patient ID / UHID : 11842044/RCL11097838 Barcode NO : BI9656565111
Referred BY : Self Sample Type : Serum
....

Sample Collected : Mar 25, 2025, 07:49 AM Report Date : Mar 25, 2025, 12:33 PM.
Test Description Value(s) Unit(s) Reference Range

Lipid Profile

Total Cholesterol 246 mg/dL <200

enzymatic CHOD-PAP
Triglycerides 235 mg/dL <150
Glycerol phosphate oxidase
HDL Cholesterol 42 mg/dL >40
cholesterol oxidase and peroxidase
Non HDL Cholesterol 204 mg/dL <130
Calculated
LDL Cholesterol 157 mg/dL <100
Calculated
V.L.D.L Cholesterol 47 mg/dL < 30
Calculated
Chol/HDL Ratio 5.86 Ratio 3.5 - 5.0
Calculated
HDL/ LDL Ratio 0.27 Ratio 0.5 - 3.0
Calculated
LDL/HDL Ratio 3.74 Ratio -
Calculated

Interpretation:
Lipid level assessments must be made following 9 to 12 hours of fasting, otherwise assay results might lead to erroneous interpretation. NCEP recommends of 3
different samples to be drawn at intervals of 1 week for harmonizing biological variables that might be encountered in single assays.

National Lipid Association Recommendations Total Cholesterol Triglyceride LDL Cholesterol Non HDL Cholesterol
(NLA-2014) (mg/dL) (mg/dL) (mg/dL) (mg/dL)
Optimal <200 <150 <100 <130
Above Optimal 100-129 130 - 159
Borderline High 200-239 150-199 130-159 160 - 189
High >=240 200-499 160-189 190 - 219
Very High - >=500 >=190 >=220

HDL Cholesterol
Low High
<40 >=60

Risk Stratification for ASCVD (Atherosclerotic Cardiovascular Disease) by Lipid Association of India.

Risk Category A. CAD with > 1 feature of high risk group

B. CAD with >1 feature of very high risk group of recurrent ACS (within 1 year) despite LDL-C <or = 50 mg/dl
Extreme risk group
or poly vascular disease
1.Established ASCVD 2.Diabetes with 2 major risk factors of evidence of end organ
Very High Risk
damage 3. Familial Homozygous Hypercholesterolemia
1. Three major ASCVD risk factors 2. Diabetes with 1 major risk factor or no evidence

Booking Centre :- Home Collection

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., Building No.168,First Floor Sarathy,9 Main Sector 6 HRS Layout,
Bangalore 560102

Page 9 of 26
Patient NAME : Mr A RAGHAVENDRA CHARYULU
DOB/Age/Gender : 40 Y 9 M 13 D/Male Report STATUS : Final Report
Patient ID / UHID : 11842044/RCL11097838 Barcode NO : BI9656565111
Referred BY : Self Sample Type : Serum
Sample Collected : Mar 25, 2025, 07:49 AM Report Date : Mar 25, 2025, 12:33 PM.
Test Description Value(s) Unit(s) Reference Range
of end organ damage 3. CHD stage 3B or 4. 4 LDL >190 mg/dl 5. Extreme of a single
High Risk
risk factor 6. Coronary Artery Calcium - CAC > 300 AU 7. Lipoprotein a >/= 50 mg/dl
8. Non stenotic carotid plaque
Moderate Risk 2 major ASCVD risk factors
Low Risk 0-1 major ASCVD risk factors

Major ASCVD (Atherosclerotic cardiovascular disease) Risk Factors

1. Age >/=45 years in Males &
3. Current Cigarette smoking or tobacco use
>/= 55 years in Females
2. Family history of premature
4. High blood pressure
ASCVD
5. Low HDL

Newer treatment goals and statin initiation thresholds based on the risk categories proposed by Lipid Association of India
in 2020.

Risk Group Treatment Goals Consider Drug Therapy

LDL-C (mg/dl) Non-HDL (mg/dl) LDL-C (mg/dl) Non-HDL (mg/dl)

Extreme Risk Group Category A <50 (Optional goal <OR = 30) <80 (Optional goal <OR = 60) >OR = 50 >OR = 80
Extreme Risk Group Category B >OR = 30 >OR = 60 > 30 > 60
Very High Risk <50 <80 >OR = 50 >OR = 80
High Risk <70 <100 >OR = 70 >OR = 100
Moderate Risk <100 <130 >OR = 100 >OR = 130
Low Risk <100 <130 >OR = 130* >OR = 160

* After an adequate non-pharmacological intervention for at least 3 months.

References : Management of Dyslipidaemia for the Prevention of Stroke : Clinical practice Recommendations from the Lipid Association of
India. Current Vascular Pharmacology,2022,20,134-155.

Booking Centre :- Home Collection

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., Building No.168,First Floor Sarathy,9 Main Sector 6 HRS Layout,
Bangalore 560102

Page 10 of 26
 Patient NAME : Mr A RAGHAVENDRA CHARYULU
DOB/Age/Gender : 40 Y 9 M 13 D/Male Report STATUS : Final Report
Patient ID / UHID : 11842044/RCL11097838 Barcode NO : BI9656565111
Referred BY : Self Sample Type : Serum
....

Sample Collected : Mar 25, 2025, 07:49 AM Report Date : Mar 25, 2025, 12:33 PM.
Test Description Value(s) Unit(s) Reference Range

Lipase

Lipase 18 U/L <67

Spectrophotometry

Interpretation:
Pancreas is the major and primary source of serum lipase though lipases are also present in liver, stomach, intestine, WBC, fat cells and milk. In
acute pancreatitis, serum lipase becomes elevated at the same time as amylase and remains high for 7-10 days. Increased
lipase activity rarely lasts longer than 14 days. Prolonged increase suggests poor prognosis or presence of a cyst. The combined use of serum
lipase and serum amylase is effective in ruling out acute pancreatitis.

Increased levels
Acute & Chronic pancreatitis
Obstruction of pancreatic duct
Non pancreatic conditions like renal diseases, acute cholecystitis, intestinal obstruction, duodenal ulcer, alcoholism, diabetic ketoacidosis and
following endoscopic retrograde cholangiopancreatography

Booking Centre :- Home Collection

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., Building No.168,First Floor Sarathy,9 Main Sector 6 HRS Layout,
Bangalore 560102

Page 11 of 26
 Patient NAME : Mr A RAGHAVENDRA CHARYULU
DOB/Age/Gender : 40 Y 9 M 13 D/Male Report STATUS : Final Report
Patient ID / UHID : 11842044/RCL11097838 Barcode NO : BI9656565111
Referred BY : Self Sample Type : Serum
....

Sample Collected : Mar 25, 2025, 07:49 AM Report Date : Mar 25, 2025, 12:33 PM.
Test Description Value(s) Unit(s) Reference Range

Amylase

Amylase 47 U/L 25 - 125

Serum,. 2-chloro-p-nitrophenyl-a-D-maltotrioside

Interpretation:
1. Amylase levels are significantly increased in patients with acute pancreatitis, pancreatic duct obstruction, carcinoma pancreas, ovaries, or lungs, cholecystitis,
macroamylasemia, renal disease, pancreatic pseudocyst, procedures like Endoscopic retrograde cholangiopancreatography and acute alcohol poisoning.
2. In acute pancreatitis, elevated amylase levels usually parallel lipase concentrations, although lipase levels may take a bit longer to rise than blood amylase levels
and will remain elevated longer.
3. Amylase levels are raised in aspirin, diuretics, oral contraceptives, corticosteroids, indomethacin, ethyl alcohol and opiate intake

Booking Centre :- Home Collection

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., Building No.168,First Floor Sarathy,9 Main Sector 6 HRS Layout,
Bangalore 560102

Page 12 of 26
 Patient NAME : Mr A RAGHAVENDRA CHARYULU
DOB/Age/Gender : 40 Y 9 M 13 D/Male Report STATUS : Final Report
Patient ID / UHID : 11842044/RCL11097838 Barcode NO : BI9656565111
Referred BY : Self Sample Type : Serum
....

Sample Collected : Mar 25, 2025, 07:49 AM Report Date : Mar 25, 2025, 12:33 PM.
Test Description Value(s) Unit(s) Reference Range

Iron Studies

Iron 210 µg/dL 65 - 175

Ferrozine
TIBC,(Total Iron Binding Capacity) 365 µg/dL 250 - 450
Calculated
UIBC 155 µg/dL 69 - 240
Ferrozine
Transferrin Saturation 57.53 % 14 - 50
Calculated

Interpretation:
Increased levels due to iron ingestion or ineffective erythropoiesis.Decreased levels due to infection, inflammation, malignancy, menstruation and
Fe deficiency.Needs to be taken into consideration with TIBC. Transferrin Saturation:- Low level Transferrin Saturation can indicate iron
deficiency, erythropoiesis, infection, or inflammation. High level Transferrin Saturation can indicate recent ingestion of dietary iron,ineffective
erythropoiesis,haemochromatosis or liver disease.High TIBC, UIBC, or transferrin usually indicates iron deficiency, but they are also increased in
pregnancy and with the use of oral contraceptives. Low TIBC, UIBC, or transferrin may occur if someone has:Hemochromatosis, Certain types of
anemia due to accumulated iron,Malnutrition,kidney disease that causes a loss of protein in urine.

Booking Centre :- Home Collection

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., Building No.168,First Floor Sarathy,9 Main Sector 6 HRS Layout,
Bangalore 560102

Page 13 of 26
 Patient NAME : Mr A RAGHAVENDRA CHARYULU
DOB/Age/Gender : 40 Y 9 M 13 D/Male Report STATUS : Final Report
Patient ID / UHID : 11842044/RCL11097838 Barcode NO : BI9656565111
Referred BY : Self Sample Type : Serum
....

Sample Collected : Mar 25, 2025, 07:49 AM Report Date : Mar 25, 2025, 12:33 PM.
Test Description Value(s) Unit(s) Reference Range

C-Reactive Protein (CRP), Quantitative

CRP (Quantitative) 3.2 mg/L up to 5

Immunoturbidimetry

Interpretation:
Increased CRP level:
1. A high or increasing amount of CRP in the blood suggests the presence of inflammation but will not identify its location or the cause.
2. Suspected bacterial infection—a high CRP level can provide indication that patient has an infection.
3. Chronic inflammatory disease—high levels of CRP suggest a flare-up if you have a chronic inflammatory disease or that treatment has not
been effective.
If the CRP level is initially elevated and drops, it means that the inflammation or infection is subsiding and/or responding to treatment.

Booking Centre :- Home Collection

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., Building No.168,First Floor Sarathy,9 Main Sector 6 HRS Layout,
Bangalore 560102

Page 14 of 26
 Patient NAME : Mr A RAGHAVENDRA CHARYULU
DOB/Age/Gender : 40 Y 9 M 13 D/Male Report STATUS : Final Report
Patient ID / UHID : 11842044/RCL11097838 Barcode NO : BI9656565111
Referred BY : Self Sample Type : Serum
....

Sample Collected : Mar 25, 2025, 07:49 AM Report Date : Mar 25, 2025, 12:33 PM.
Test Description Value(s) Unit(s) Reference Range

High Sensitivity C-Reactive Protein (Hs-CRP)

HIGHLY SENSITIVE C-REACTIVE PROTEIN (hs- 3.06 mg/L < 1.00

CRP)
immunoturbidimetric

Interpretation:

Cardio CRP In mg/L Cardiovascular Risk

<1 Low
1-3 Average
3-10 High
Persistent elevation may represent
>10
Non cardiovascular inflammation

Note: To assess vascular risk, it is recommended to test hsCRP levels 2 or more weeks apart and calculate the average

Comments:
High sensitivity C Reactive Protein (hsCRP) significantly improves cardiovascular risk assessment as it is a strongest predictor of future
coronary events. It reveals the risk of future Myocardial infarction and Stroke among healthy men and women, independent of traditional risk
factors. It identifies patients at risk of first Myocardial infarction even with low to moderate lipid levels. The risk of recurrent cardiovascular events
also correlates well with hsCRP levels. It is a powerful independent risk determinant in the prediction of incident Diabetes.

Booking Centre :- Home Collection

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., Building No.168,First Floor Sarathy,9 Main Sector 6 HRS Layout,
Bangalore 560102

Page 15 of 26
 Patient NAME : Mr A RAGHAVENDRA CHARYULU
DOB/Age/Gender : 40 Y 9 M 13 D/Male Report STATUS : Final Report
Patient ID / UHID : 11842044/RCL11097838 Barcode NO : BI9656565111
Referred BY : Self Sample Type : Serum
....

Sample Collected : Mar 25, 2025, 07:49 AM Report Date : Mar 25, 2025, 12:33 PM.
Test Description Value(s) Unit(s) Reference Range

Rheumatoid Factor (RF), Quantitative

RHEUMATOID FACTOR, Quantitative 20 IU/mL Negative <30

Immunoturbidimetry Weakly positive 30 to 50
Positive >50
Interpretation:
Approximately 85% of patients with Rheumatoid arthritis have detectable RA. It may also be seen in other medical conditions like Sjogren’s
syndrome and SLE.

Booking Centre :- Home Collection

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., Building No.168,First Floor Sarathy,9 Main Sector 6 HRS Layout,
Bangalore 560102

Page 16 of 26
 Patient NAME : Mr A RAGHAVENDRA CHARYULU
DOB/Age/Gender : 40 Y 9 M 13 D/Male Report STATUS : Final Report
Patient ID / UHID : 11842044/RCL11097838 Barcode NO : BI9656565111
Referred BY : Self Sample Type : Serum
....

Sample Collected : Mar 25, 2025, 07:49 AM Report Date : Mar 25, 2025, 12:33 PM.
Test Description Value(s) Unit(s) Reference Range

Vitamin B12 / Cyanocobalamin

Vitamin - B12 148 pg/mL 187 - 883

CMIA

Interpretation:
Low Values are a sign of a vitamin B12 deficiency. People with this deficiency are likely to have or develop symptoms.
Causes of vitamin B12 deficiency include:Not enough vitamin B12 in diet (rare except with a strict vegetarian diet), Diseases that cause
malabsorption (for example, celiac disease and Crohn's disease), Lack of intrinsic factor, Above normal heat production (for example, with
hyperthyroidism), Pregnancy. Increased vitamin B12 levels are uncommon. Usually excess vitamin B12 is removed in the urine. Conditions that can
increase B12 levels include: Liver disease (such as cirrhosis or hepatitis), Myeloproliferative disorders (for example, polycythemia vera and chronic
myelocytic leukemia).
Vitamin B12: Low Levels can cause malabsorption, Lack of intrinsic factor, Above normal heat production (for example, with hyperthyroidism),
Pregnancy.High Level Liver disease, Myeloproliferative disorders (for example, polycythemia vera and chronic myelocytic leukemia).
1. Out of 140 healthy indian population, 91% of Vitamin B 12 concentrations was at lower level: 59.00 pg/ml and upper level: 700.00 pg/ml

"Patients on Biotin supplement may have interference in some immunoassays. Ref: Arch Pathol Lab Med—Vol 141, November 2017. With
individuals taking high dose Biotin (more than 5 mg per day) supplements, at least 8-hour wait time before blood draw is recommended."

Booking Centre :- Home Collection

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., Building No.168,First Floor Sarathy,9 Main Sector 6 HRS Layout,
Bangalore 560102

Page 17 of 26
 Patient NAME : Mr A RAGHAVENDRA CHARYULU
DOB/Age/Gender : 40 Y 9 M 13 D/Male Report STATUS : Final Report
Patient ID / UHID : 11842044/RCL11097838 Barcode NO : BI9656565111
Referred BY : Self Sample Type : Serum
....

Sample Collected : Mar 25, 2025, 07:49 AM Report Date : Mar 25, 2025, 12:33 PM.
Test Description Value(s) Unit(s) Reference Range

Vitamin D 25 Hydroxy

Vitamin D 25 - Hydroxy 7.57 ng/mL Deficiency:<10ng/ml

CMIA Insufficient:10-30ng/ml
Sufficient:>30-100ng/ml
Hypervitaminosis:>100ng/ml
Interpretation:
25-Hydroxy vitamin D represents the main body reservoir and transport form. Mild to moderate deficiency is associated with Osteoporosis /
Secondary Hyperparathyroidism while severe deficiency causes Rickets in children and Osteomalacia in adults. Prevalence of Vitamin D
deficiency is approximately >50% specially in the elderly. This assay is useful for diagnosis of vitamin D deficiency and Hypervitaminosis D. It is
also used for differential diagnosis of causes of Rickets & Osteomalacia and for monitoring Vitamin D replacement therapy.

Booking Centre :- Home Collection

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., Building No.168,First Floor Sarathy,9 Main Sector 6 HRS Layout,
Bangalore 560102

Page 18 of 26
 Patient NAME : Mr A RAGHAVENDRA CHARYULU
DOB/Age/Gender : 40 Y 9 M 13 D/Male Report STATUS : Final Report
Patient ID / UHID : 11842044/RCL11097838 Barcode NO : BI9656565111
Referred BY : Self Sample Type : Serum
....

Sample Collected : Mar 25, 2025, 07:49 AM Report Date : Mar 25, 2025, 12:33 PM.
Test Description Value(s) Unit(s) Reference Range

Thyroid Profile Total

Triiodothyronine (T3) 120.8 ng/dL 35 - 193

CMIA
Total Thyroxine (T4) 7.99 µg/dL 4.87 - 11.2
CMIA
Thyroid Stimulating Hormone (Ultrasensitive) 2.19 µIU/mL 0.35 - 4.94
CMIA

Interpretation:
Pragnancy Refrence Range TSH
1st Trimester 0 .1 - 2.5
2nd Trimester 0.2 - 3.0
3rd Trimester 3.0 - 3.0

Clinical Use:
1. Diagnose Hypothyroidism & Hyperthyroidism
2. Monitor T4 therapy
3. Measure subnormal TSH levels

Increased TSH: Primary hypothyroidism, Subclinical hypothyroidism, TSH-dependent hyperthyroidism, Thyroid hormone resistance
Decreased TSH: Graves’ disease, Autonomous thyroid hormone secretion, TSH deficiency

Thyroid malfunction (hyper or hypo) affects T3 & T4 levels. Pituitary or hypothalamic issues also influence thyroid activity.

1. Primary Hypothyroidism: High TSH levels.

2. Secondary/Tertiary Hypothyroidism: Low TSH levels.
3. Euthyroid Sick Syndrome: Abnormal thyroid test results due to non-thyroidal illnesses (NTI).

TBG levels are stable in healthy individuals but may be altered by pregnancy, estrogens, androgens, steroids, or glucocorticoids, causing inaccurate T3 & T4
readings.

TSH T4 T3 Interpretation
High Normal Normal Mild (subclinical) hypothyroidism
High Low Low Or Nomral Hypothyroidism
Low Normal Normal Mild (subclinical) hyperthyroidism
Low High Or Normal High Or Normal Hyperthyroidism
Low Low Or Normal Low Or Normal Nonthyroidal illness; pituitary (secondary) hypothyroidism
Thyroid hormone resistance syndrome (a mutation in the thyroid hormone
Normal High High
receptor decreases thyroid hormone function)

Booking Centre :- Home Collection

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., Building No.168,First Floor Sarathy,9 Main Sector 6 HRS Layout,
Bangalore 560102

Page 19 of 26
 Patient NAME : Mr A RAGHAVENDRA CHARYULU
DOB/Age/Gender : 40 Y 9 M 13 D/Male Report STATUS : Final Report
Patient ID / UHID : 11842044/RCL11097838 Barcode NO : BI9656565111
Referred BY : Self Sample Type : Serum
....

Sample Collected : Mar 25, 2025, 07:49 AM Report Date : Mar 25, 2025, 12:33 PM.
Test Description Value(s) Unit(s) Reference Range

Testosterone Total

Testosterone Total 306.06 ng/dL 249 - 836

CMIA

Interpretation:
Age in Years Reference Ranges ng/dL
Males 20-49 249 - 836
Males ≥ 50 years 193 - 740
Females 20-49 8.4 - 48.1
Females ≥ 50 2.9 - 40.8

Reference values for Males (7-18 years) characterized by Tanner Stage

Tanner Stage 5-95th percentiles (ng/dL)
1 < 2.5
2 < 2.5 - 432
3 64.9 - 778
4 180 - 763
5 188 - 882

Reference values for females (8-18 years) characterized by Tanner Stage

Tanner Stage 5-95th percentiles (ng/dL)
1 <2.5 - 6.1
2 <2.5 - 10.4
3 <2.5 - 23.7
4 <2.5 - 26.8
5 4.6 - 38.3

Note
ꞏ All applications that require measurement of very low level of testosterone ( eg hypogonadal men, children, virilization or intersex disorders in
women etc) recommended test is Testosterone total, Ultrasensitive

ꞏ LC-MS/MS is the gold standard for steroid hormone assays due to increased sensitivity & specificity as compared to immunoassays
Clinical Use
ꞏ Assessment of testicular function in males
Increased levels
ꞏ Precocious puberty (Males)
ꞏ Androgen resistance
ꞏ Testotoxicosis
ꞏ Congenital Adrenal Hyperplasia

Booking Centre :- Home Collection

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., Building No.168,First Floor Sarathy,9 Main Sector 6 HRS Layout,
Bangalore 560102

Page 20 of 26
Patient NAME : Mr A RAGHAVENDRA CHARYULU
DOB/Age/Gender : 40 Y 9 M 13 D/Male Report STATUS : Final Report
Patient ID / UHID : 11842044/RCL11097838 Barcode NO : BI9656565111
Referred BY : Self Sample Type : Serum
Sample Collected : Mar 25, 2025, 07:49 AM Report Date : Mar 25, 2025, 12:33 PM.
Test Description Value(s) Unit(s) Reference Range
Decreased levels
ꞏ Delayed puberty ( Males)
ꞏ Gonadotropin deficiency
ꞏ Testicular defects
ꞏ Systemic diseases

Prostate Specific Antigen (PSA) Total

Prostate Specific Antigen-Total (PSA-Total) 0.477 ng/mL <4.0

CMIA

Interpretation:
Age (years) Ranges

< 40 <1.4

40 - 49 <2.0

50 - 59 <3.1

60 - 69 <4.1

>=70 <4.4

Prostate Specific Antigen (PSA) is a single-chain glycoprotein normally found in the cytoplasm of the epithelial cells lining the acini and ducts of the prostate gland. PSA is detected in the serum of males with normal, benign hyperplastic
and malignant prostate tissue and in patients with prostatitis. PSA is not detected (or detected at very low levels) in the serum of males without prostate tissue (because of radical prostatectomy or cytoprostatectomy) or in the serum of
most females. The fact that PSA is unique to prostate tissue makes it a suitable marker for monitoring men with cancer of the prostate. PSA is also useful for determining possible recurrence after therapy when used in conjunction with
other diagnostic indices. PSA levels increase in men with cancer of the prostate. After radical prostatectomy PSA levels routinely fall to a very low level, which may not be seen in patients undergoing radiation therapy. Monitoring PSA
levels appears to be useful in detecting residual disease and early recurrence of tumor. Therefore, serial PSA levels can help determine the success of prostatectomy and the need for further treatment, such as radiation, endocrine of
chemotherapy and in the monitoring of the effectiveness of therapy.
PSA levels should not be interpreted as absolute evidence of presence or the absence of malignant disease. Before treatment, patients with confirmed prostate carcinoma frequently have levels of PSA within the range observed in healthy
individuals. Elevated levels of PSA can be observed in the patients with nonmalignant disease. Measurement of PSA should always be used in conjunction with other diagnostic procedures, including information from the patients and
clinical evaluation.
The concentration of total PSA in a given specimen determined with assays from different manufacturers can vary due to differences in assay methods, calibration, and reagent specificity.

Booking Centre :- Home Collection

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., Building No.168,First Floor Sarathy,9 Main Sector 6 HRS Layout,
Bangalore 560102

Page 21 of 26
 Patient NAME : Mr A RAGHAVENDRA CHARYULU
DOB/Age/Gender : 40 Y 9 M 13 D/Male Report STATUS : Final Report
Patient ID / UHID : 11842044/RCL11097838 Barcode NO : BI9656565111
Referred BY : Self Sample Type : Serum
....

Sample Collected : Mar 25, 2025, 07:49 AM Report Date : Mar 25, 2025, 12:33 PM.
Test Description Value(s) Unit(s) Reference Range

Creatine Phosphokinase (CPK)

Creatine Kinase-CPK 50 U/L 46 - 171

NAC (N - Acetyl - L - Cysteine

Interpretation:
High CPK levels may be seen in patients who have Brain injury or stroke, Convulsions, Delirium tremens, Dermatomyositis or
polymyositis, Electric shock, Heart attack, Inflammation of the heart muscle (myocarditis), Lung tissue death (pulmonary infarction), Muscular
dystrophies, Myopathy.

Apolipoproteins A1 & B

Apolipoprotein A-1 (APO-A) 149 mg/dL 104 - 202

Tina-quant
Apolipoprotein B (APO-B) 117 mg/dL 66 - 144
Tina-quant
Apo B / Apo A1 Ratio 0.79
Interpretation:
The Apo A1 and Apo B blood tests are crucial for assessing lipid metabolism and cardiovascular risk. High Apo A1 and low Apo B levels are
associated with a lower risk of cardiovascular disease, while low Apo A1 and high Apo B levels indicate a higher risk. Management involves
lifestyle modifications, medications, and regular monitoring to maintain optimal lipid levels and reduce cardiovascular risk. Consulting
healthcare providers for accurate interpretation and tailored treatment plans is essential for effective management.

Booking Centre :- Home Collection

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., Building No.168,First Floor Sarathy,9 Main Sector 6 HRS Layout,
Bangalore 560102

Page 22 of 26
 Patient NAME : Mr A RAGHAVENDRA CHARYULU
DOB/Age/Gender : 40 Y 9 M 13 D/Male Report STATUS : Final Report
Patient ID / UHID : 11842044/RCL11097838 Barcode NO : 9656565111
Referred BY : Self Sample Type : Serum
....

Sample Collected : Mar 25, 2025, 07:49 AM Report Date : Mar 25, 2025, 02:12 PM.
Test Description Value(s) Unit(s) Reference Range

Hepatitis C Antibody (HCV), Rapid Card

HEPATITIS C ANTIBODY (Anti-HCV) NON REACTIVE NON REACTIVE

Qualitative immunoassay,rapid card

Interpretation:
RESULTS REMARKS
Reactive Reactive test result indicates presence of Hepatitis C virus infection
Non Reactive Non Reactive test result indicates absence of Hepatitis C virus infection

NOTE
1.The 4TH Generation HCV TRI-DOT detects anti-HCV in human serum or plasma and is only a screening test. All reactive samples should be
confirmed by supplemental assays like RIBA .Therefore for a definitive diagnosis, the patient's clinical history ,symptomatalogy as well as
serological data, should be considered. The results should be reported only after complying with above procedure.
2.A non reactive-results does not exclude the possibility of exposure to or infection with HCV.
3.Repeated false results may occur due to non-specefic binding of the sample to the membrane.
4.The presence of anti-HCV does not imply a HepatitisC infection but may be indicative of recent and /or past infection By HCV.
5.Patients with auto-immune liver diseases may show falsely reactive results.
6. False positive results may be observed in patients receiving mouse monoclonal antibodies, on heparin therapy, on biotin supplements for
diagnosis or therapy or presence of heterophilic antibodies in serum.
5. False negative reaction may be due to processing of sample collected early in the course of disease, Prozone phenomenon,
Immunosuppression & Immuno-incompetence.

Uses ꞏ
To diagnose suspected HCV infection in risk group.
Prenatal Screening of pregnant women and pre surgical/interventional procedures work up.

Booking Centre :- Home Collection

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., Building No.168,First Floor Sarathy,9 Main Sector 6 HRS Layout,
Bangalore 560102

Page 23 of 26
Patient NAME : Mr A RAGHAVENDRA CHARYULU
DOB/Age/Gender : 40 Y 9 M 13 D/Male Report STATUS : Final Report
Patient ID / UHID : 11842044/RCL11097838 Barcode NO : 9656565111
Referred BY : Self Sample Type : Serum
Sample Collected : Mar 25, 2025, 07:49 AM Report Date : Mar 25, 2025, 02:12 PM.
Test Description Value(s) Unit(s) Reference Range

Hepatitis B Surface Antigen (HBsAg), Rapid Card

HEPATITIS B SURFACE ANTIGEN (HBsAg) NON REACTIVE NON REACTIVE

Qualitative immunoassay,rapid card

Interpretation:
RESULTS REMARKS
Reactive The sample is Reactive for HBsAg
Non Reactive The sample is Non Reactive for HBsAg

Note
1.This is only a Screening test. All reactive results should be confirmed by confirmatory test. Therefore for a definitive diagnosis, the patient's
clinical history ,symptomatalogy as well as serological data, should be considered. The results should be reported only after complying with above
procedure.
2. Additional follow up testing using available clinical methods (along with repeat HBsAg rapid card test) is required, if the test is Non reactive
with persisting clinical symptoms
3. False positive results may be observed in patients receiving mouse monoclonal antibodies, on heparin therapy, on biotin supplements for
diagnosis or therapy, presence of heterophilic antibodies in serum or after HBV vaccination for transient period of time.
4. False negative reaction may be due to processing of sample collected early in the course of disease or presence of mutant forms of HBsAg.

Booking Centre :- Home Collection

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., Building No.168,First Floor Sarathy,9 Main Sector 6 HRS Layout,
Bangalore 560102

Page 24 of 26
 Patient NAME : Mr A RAGHAVENDRA CHARYULU
DOB/Age/Gender : 40 Y 9 M 13 D/Male Report STATUS : Final Report
Patient ID / UHID : 11842044/RCL11097838 Barcode NO : 34511132
Referred BY : Self Sample Type : Spot Urine
....

Sample Collected : Mar 25, 2025, 07:49 AM Report Date : Mar 25, 2025, 10:43 AM.
Test Description Value(s) Unit(s) Reference Range

Urine Routine and Microscopic Examination

Physical Examination
Volume 20 mL
visual
Colour Pale Yellow Pale yellow
visual
Transparency Clear Clear
visual
Deposit Absent Absent
visual
Chemical Examination
Reaction (pH) 7.0 5.5-8.0
Double Indicator
Specific Gravity 1.010 0 1.010 - 1.030
Ion Exchange.
Urine Glucose (sugar) Negative Negative
Oxidase / Peroxidase
Urine Protein (Albumin) Negative Negative
bromophenol blue
Urine Ketones (Acetone) Negative Negative
Legals Test
Blood Negative Negative
Peroxidase Hemoglobin
Leucocyte esterase Negative Negative
amino acid aster
Bilirubin Urine Negative Negative
Diazotized dicholoroaniline
Nitrite Negative Negative
Griless Test
Urobilinogen Normal Normal
Ehrlichs Test
Microscopic Examination
Pus Cells (WBCs) 4-5 /hpf 0-5
WET MOUNT
Epithelial Cells 2-3 /hpf 0-4
WET MOUNT
Red blood Cells Absent /hpf Absent
WET MOUNT
Crystals Absent Absent
WET MOUNT
Cast Absent Absent
WET MOUNT
Yeast Cells Absent Absent
WET MOUNT

Booking Centre :- Home Collection

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., Building No.168,First Floor Sarathy,9 Main Sector 6 HRS Layout,
Bangalore 560102

Page 25 of 26
Patient NAME : Mr A RAGHAVENDRA CHARYULU
DOB/Age/Gender : 40 Y 9 M 13 D/Male Report STATUS : Final Report
Patient ID / UHID : 11842044/RCL11097838 Barcode NO : 34511132
Referred BY : Self Sample Type : Spot Urine
Sample Collected : Mar 25, 2025, 07:49 AM Report Date : Mar 25, 2025, 10:43 AM.
Test Description Value(s) Unit(s) Reference Range
Amorphous deposits Absent Absent
WET MOUNT
Bacteria Absent Absent
WET MOUNT
Protozoa Absent Absent
WET MOUNT

Interpretation:
URINALYSIS- Routine urine analysis assists in screening and diagnosis of various metabolic, urological, kidney and liver disorders.

Protein: Elevated proteins can be an early sign of kidney disease. Urinary protein excretion can also be temporarily elevated by strenuous
exercise, orthostatic proteinuria, dehydration, urinary tract infections and acute illness with fever

Glucose: Uncontrolled diabetes mellitus can lead to presence of glucose in urine. Other causes include pregnancy, hormonal disturbances,
liver disease and certain medications.

Ketones: Uncontrolled diabetes mellitus can lead to presence of ketones in urine. Ketones can also be seen in starvation, frequent vomiting,
pregnancy and strenuous exercise.

Blood: Occult blood can occur in urine as intact erythrocytes or haemoglobin, which can occur in various urological, nephrological and bleeding
disorders.

Leukocytes: An increase in leukocytes is an indication of inflammation in urinary tract or kidneys. Most common cause is bacterial urinary tract
infection.

Nitrite: Many bacteria give positive results when their number is high. Nitrite concentration during infection increases with length of time the
urine specimen is retained in bladder prior to collection.

pH: The kidneys play an important role in maintaining acid base balance of the body. Conditions of the body producing acidosis/ alkalosis or
ingestion of certain type of food can affect the pH of urine.

Specific gravity: Specific gravity gives an indication of how concentrated the urine is. Increased specific gravity is seen in conditions like
dehydration, glycosuria and proteinuria while decreased specific gravity is seen in excessive fluid intake, renal failure and diabetes insipidus.

Bilirubin: In certain liver diseases such as biliary obstruction or hepatitis, bilirubin gets excreted in urine.

Urobilinogen: Positive results are seen in liver diseases like hepatitis and cirrhosis and in cases of haemolytic anaemia.

*** End Of Report ***

Booking Centre :- Home Collection

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., Building No.168,First Floor Sarathy,9 Main Sector 6 HRS Layout,
Bangalore 560102

Page 26 of 26